Powered by
Alimera Sciences Reports Record Fourth Quarter and Full Year 2016 Financial Results

Fourth Quarter and Full Year Ended 2016 Highlights

Annual revenue increased 53% for 2016 compared to 2015Record fourth quarter 2016 revenue of $10.7 million represents an 84% increase over fourth quarter 2015Alimera expects its distributors in Italy and the Middle East to further the availability of ILUVIEN in 2017Alimera to host conference call on March 2, 2017 at 10:00 AM ET

ATLANTA, March 01, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a global pharm

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 10 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox